I must confess that I put him on ignore a long time ago. But as I recall when the share price was in the 20 cent range he was saying that PPHM was a disaster and telling folks that it was headed for the teens!
Meanwhile I am just waiting for more news. I will be surprised if the survival data does not exceed AVASTIN's. And I am looking forward to the "armed" BAVI trials....I expect to see them in both cancer and viral uses.